ArticleBreast cancer research and treatment2026
Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer.
Tanvi Chiddarwar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it